New Evidence Available
Updated Recommendation
A new evidence synthesis was published:2025, Medical eligibility criteria for contraceptive use, 6th ed.
View latest version (2025)Bibliographic information
GuidelineMedical eligibility criteria for contraceptive use
Year of Publication2015
Issuing InstitutionWorld Health Organization
Recommendation
Retired
Women using Non-nucleoside/ nucleotide reverse transcriptase inhibitors (NNRTIs) containing either efavirenz or nevirapine can generally use combined oral contraceptive (pill) (COCs), combined injectable contraceptives (CICs), combined contraceptive patches and rings, progestogen-only pill(POPs), progestogen-only injectable(POIs) (DMPA and NET-EN), and levonorgestrel (LNG) and etonogestrel(ETG) implants
Certainty of evidence
Low